Skip to main content

Market Overview

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND)

123.82 0.00 (0.00%)

Earnings

QuarterPriorEstimateActualSurprise
Q1 2022
After-Hours
EPS:
REV:




Q4 2021
Pre-Market
EPS:
REV:




Q3 2021
Pre-Market
EPS:
REV:
1.04
41.848M



Q2 2021
Pre-Market
EPS:
REV:




Q1 2021
After-Hours
EPS:
REV:
0.89
33.161M
1.12
62.85M
1.41
55.15M
25.89%
-12.25%
Q4 2020
Pre-Market
EPS:
REV:
0.71
27.003M
0.99
54.09M
1.62
69.99M
63.64%
29.4%
Q3 2020
Pre-Market
EPS:
REV:
0.49
24.808M
0.98
44.36M
1.04
41.848M
6.12%
-5.66%
Q2 2020
Pre-Market
EPS:
REV:
0.68
24.987M
0.76
29.96M
1
41.42M
31.58%
38.25%
Q1 2020
After-Hours
EPS:
REV:
1.16
43.484M
0.66
26.53M
0.89
33.161M
34.85%
24.99%
Q4 2019
After-Hours
EPS:
REV:
1.7
59.59M
0.61
25.16M
0.71
27.003M
16.39%
7.33%

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!